These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 28893837)

  • 21.
    Chen T; Olsen I
    J Oral Microbiol; 2019; 11(1):1638196. PubMed ID: 31303969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutting it close: CRISPR-associated endoribonuclease structure and function.
    Hochstrasser ML; Doudna JA
    Trends Biochem Sci; 2015 Jan; 40(1):58-66. PubMed ID: 25468820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of CRISPR/Cas system of Proteus and the factors affected the functional mechanism.
    Qu D; Lu S; Wang P; Jiang M; Yi S; Han J
    Life Sci; 2019 Aug; 231():116531. PubMed ID: 31175856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hot and crispy: CRISPR-Cas systems in the hyperthermophile Sulfolobus solfataricus.
    Zhang J; White MF
    Biochem Soc Trans; 2013 Dec; 41(6):1422-6. PubMed ID: 24256231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity.
    Faure G; Makarova KS; Koonin EV
    J Mol Biol; 2019 Jan; 431(1):3-20. PubMed ID: 30193985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial expression, purification, and initial characterization of a full-length Cas13b protein from Porphyromonas gingivalis.
    Zhu J; Zhou X; Huang X; Du Z
    Protein Expr Purif; 2020 May; 169():105588. PubMed ID: 32006655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity of CRISPR/Cas system in Clostridium perfringens.
    Long J; Xu Y; Ou L; Yang H; Xi Y; Chen S; Duan G
    Mol Genet Genomics; 2019 Oct; 294(5):1263-1275. PubMed ID: 31134321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex.
    Numata T; Inanaga H; Sato C; Osawa T
    J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The host-encoded RNase E endonuclease as the crRNA maturation enzyme in a CRISPR-Cas subtype III-Bv system.
    Behler J; Sharma K; Reimann V; Wilde A; Urlaub H; Hess WR
    Nat Microbiol; 2018 Mar; 3(3):367-377. PubMed ID: 29403013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria.
    Nussenzweig PM; Marraffini LA
    Annu Rev Genet; 2020 Nov; 54():93-120. PubMed ID: 32857635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR regulation of intraspecies diversification by limiting IS transposition and intercellular recombination.
    Watanabe T; Nozawa T; Aikawa C; Amano A; Maruyama F; Nakagawa I
    Genome Biol Evol; 2013; 5(6):1099-114. PubMed ID: 23661565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of direct repeats, spacers and proteins associated with clustered regularly interspaced short palindromic repeat (CRISPR) system of Vibrio parahaemolyticus.
    Baliga P; Shekar M; Venugopal MN
    Mol Genet Genomics; 2019 Feb; 294(1):253-262. PubMed ID: 30357478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
    Osawa T; Inanaga H; Sato C; Numata T
    Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virulence of the Pathogen Porphyromonas gingivalis Is Controlled by the CRISPR-Cas Protein Cas3.
    Solbiati J; Duran-Pinedo A; Godoy Rocha F; Gibson FC; Frias-Lopez J
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32994292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptation in CRISPR-Cas Systems.
    Sternberg SH; Richter H; Charpentier E; Qimron U
    Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
    O'Connell MR
    J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and applications of Type I CRISPR-Cas systems.
    Hidalgo-Cantabrana C; Barrangou R
    Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR-Cas adaptation: insights into the mechanism of action.
    Amitai G; Sorek R
    Nat Rev Microbiol; 2016 Feb; 14(2):67-76. PubMed ID: 26751509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.